Tag Archive | "Sanofi"

Myokardia forms pharma partnership with Sanofi for Cardiomyopathy

Tags: , , , , ,


Sanofi forms pharma partnership with MyoKardia on a $200 million initiative to develop new therapies to help treat deadly genetic heart muscle disease. Read the full story

Omega Pharma rumored to be sought after by big pharma companies

Tags: , , , , ,


Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company.  Read the full story

Illumina join hands with AstraZeneca, Janssen Biotech and Sanofi

Tags: , , , , ,


Illumina has formed a collaborative partnership with leading pharmaceutical companies AstraZeneca, Janssen Biotech and Sanofi. Read the full story

Sanofi signs a pharma deal with Mannkind for $925 million

Tags: , , ,


Sanofi and Mannkind had entered into a collaboration and license agreement to commercialize Afrezza Inhalation Powder. Read the full story

CureVac and Sanofi sign a pharma licensing agreement

Tags: , , ,


CureVac announced the execution of a an exclusive pharma licensing agreement with Sanofi Pasteur to develop and commercialize an mRNA-based vaccine against an undisclosed pathogen. Read the full story

Sanofi and Medtronic form a pharma partnership

Tags: , , , ,


Sanofi was teaming up with U.S. medical device maker Medtronic in a pharma partnership for diabetes. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Sanofi

Tags: , ,


Sanofi is a top pharmaceutical company based in Paris, France Read the full story

Sanofi seeking to dispose of mature product portfolio

Tags: ,


Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion Read the full story

Sanofi to divest portfolio of mature drugs for $7 billion

Tags: ,


Sanofi SA is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, according to people familiar with the matter, yet another example of drugmakers trying to shed non-core assets and focus on high-growth areas. Read the full story